Maite Timmermans

533 total citations
16 papers, 332 citations indexed

About

Maite Timmermans is a scholar working on Reproductive Medicine, Obstetrics and Gynecology and Surgery. According to data from OpenAlex, Maite Timmermans has authored 16 papers receiving a total of 332 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Reproductive Medicine, 12 papers in Obstetrics and Gynecology and 11 papers in Surgery. Recurrent topics in Maite Timmermans's work include Ovarian cancer diagnosis and treatment (14 papers), Endometrial and Cervical Cancer Treatments (11 papers) and Intraperitoneal and Appendiceal Malignancies (9 papers). Maite Timmermans is often cited by papers focused on Ovarian cancer diagnosis and treatment (14 papers), Endometrial and Cervical Cancer Treatments (11 papers) and Intraperitoneal and Appendiceal Malignancies (9 papers). Maite Timmermans collaborates with scholars based in Netherlands, Belgium and United States. Maite Timmermans's co-authors include Maaike A. van der Aa, Roy F.P.M. Kruitwagen, Gabe S. Sonke, Koen Van de Vijver, Anne M. van Altena, Roy Lalisang, Ignace H. J. T. de Hingh, Koen P. Rovers, Dorry Boll and Toon Van Gorp and has published in prestigious journals such as European Journal of Cancer, Gynecologic Oncology and Acta Oncologica.

In The Last Decade

Maite Timmermans

16 papers receiving 329 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Maite Timmermans Netherlands 11 233 176 125 65 39 16 332
Kara Judson United States 7 241 1.0× 127 0.7× 113 0.9× 45 0.7× 56 1.4× 8 298
Henrique Mantoan Brazil 13 228 1.0× 149 0.8× 298 2.4× 56 0.9× 45 1.2× 36 420
Herbert Diebolder Germany 13 293 1.3× 122 0.7× 245 2.0× 34 0.5× 29 0.7× 23 417
J. Lang United States 5 456 2.0× 365 2.1× 239 1.9× 50 0.8× 52 1.3× 6 500
Levon Badiglian‐Filho Brazil 13 170 0.7× 188 1.1× 279 2.2× 45 0.7× 35 0.9× 48 436
Bjoern Lampe Germany 9 186 0.8× 154 0.9× 220 1.8× 67 1.0× 19 0.5× 12 334
M. Amoroso Italy 7 122 0.5× 108 0.6× 216 1.7× 38 0.6× 31 0.8× 14 332
Lillian Yuri Kumagai Brazil 15 170 0.7× 231 1.3× 310 2.5× 96 1.5× 63 1.6× 41 501
Carlos Chaves Faloppa Brazil 17 199 0.9× 234 1.3× 356 2.8× 93 1.4× 65 1.7× 48 570
Marjolein Kleppe Netherlands 8 311 1.3× 151 0.9× 228 1.8× 38 0.6× 21 0.5× 11 361

Countries citing papers authored by Maite Timmermans

Since Specialization
Citations

This map shows the geographic impact of Maite Timmermans's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Maite Timmermans with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Maite Timmermans more than expected).

Fields of papers citing papers by Maite Timmermans

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Maite Timmermans. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Maite Timmermans. The network helps show where Maite Timmermans may publish in the future.

Co-authorship network of co-authors of Maite Timmermans

This figure shows the co-authorship network connecting the top 25 collaborators of Maite Timmermans. A scholar is included among the top collaborators of Maite Timmermans based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Maite Timmermans. Maite Timmermans is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Timmermans, Maite, et al.. (2024). Effect of uterine manipulator on oncologic outcome in early-stage, low-grade endometrial cancer. International Journal of Gynecological Cancer. 35(2). 100047–100047. 1 indexed citations
2.
Timmermans, Maite, Maaike A. van der Aa, Dorry Boll, et al.. (2020). Incidence and predictors of peritoneal metastases of gynecological origin: a population-based study in the Netherlands. Journal of Gynecologic Oncology. 31(5). e58–e58. 43 indexed citations
3.
Timmermans, Maite, Heidi P. Fransen, Maaike A. van der Aa, et al.. (2019). Treatment patterns and associated factors in patients with advanced epithelial ovarian cancer: a population-based study. International Journal of Gynecological Cancer. 29(6). 1032–1037. 10 indexed citations
4.
Timmermans, Maite, Olga van der Hel, Gabe S. Sonke, et al.. (2019). The prognostic value of residual disease after neoadjuvant chemotherapy in advanced ovarian cancer; A systematic review. Gynecologic Oncology. 153(2). 445–451. 22 indexed citations
5.
Timmermans, Maite, et al.. (2019). Perioperative change in CA125 is an independent prognostic factor for improved clinical outcome in advanced ovarian cancer. European Journal of Obstetrics & Gynecology and Reproductive Biology. 240. 364–369. 7 indexed citations
6.
Hel, Olga L. van der, Maite Timmermans, Anne M. van Altena, et al.. (2019). Overview of non-epithelial ovarian tumours: Incidence and survival in the Netherlands, 1989–2015. European Journal of Cancer. 118. 97–104. 17 indexed citations
7.
Timmermans, Maite, et al.. (2019). EP1013 Overview of non-epithelial ovarian tumours: incidence and survival in the netherlands. Ghent University Academic Bibliography (Ghent University). A534.1–A534. 1 indexed citations
8.
Timmermans, Maite, Gabe S. Sonke, Koen Van de Vijver, et al.. (2019). Localization of distant metastases defines prognosis and treatment efficacy in patients with FIGO stage IV ovarian cancer. International Journal of Gynecological Cancer. 29(2). 392–397. 7 indexed citations
9.
Timmermans, Maite, Gabe S. Sonke, B.F.M. Slangen, et al.. (2019). Outcome of surgery in advanced ovarian cancer varies between geographical regions; opportunities for improvement in The Netherlands. European Journal of Surgical Oncology. 45(8). 1425–1431. 10 indexed citations
10.
Schuurman, Melinda S., Maite Timmermans, Toon Van Gorp, et al.. (2019). Trends in incidence, treatment and survival of borderline ovarian tumors in the Netherlands: a nationwide analysis. Acta Oncologica. 58(7). 983–989. 14 indexed citations
11.
Timmermans, Maite, Maaike A. van der Aa, Roy Lalisang, et al.. (2018). Interval between debulking surgery and adjuvant chemotherapy is associated with overall survival in patients with advanced ovarian cancer. Gynecologic Oncology. 150(3). 446–450. 48 indexed citations
12.
Timmermans, Maite, Gabe S. Sonke, Willemien J. van Driel, et al.. (2018). Neoadjuvant chemotherapy or primary debulking surgery in FIGO IIIC and IV patients; results from a survey study in the Netherlands. European Journal of Obstetrics & Gynecology and Reproductive Biology. 223. 98–102. 4 indexed citations
13.
Timmermans, Maite, Melinda S. Schuurman, Vincent K.Y. Ho, et al.. (2017). Centralization of ovarian cancer in the Netherlands: Hospital of diagnosis no longer determines patients' probability of undergoing surgery. Gynecologic Oncology. 148(1). 56–61. 15 indexed citations
14.
Timmermans, Maite, et al.. (2017). Only complete tumour resection after neoadjuvant chemotherapy offers benefit over suboptimal debulking in advanced ovarian cancer. European Journal of Obstetrics & Gynecology and Reproductive Biology. 219. 100–105. 15 indexed citations
15.
Timmermans, Maite, Gabe S. Sonke, Koen Van de Vijver, Maaike A. van der Aa, & Roy F.P.M. Kruitwagen. (2017). No improvement in long-term survival for epithelial ovarian cancer patients: A population-based study between 1989 and 2014 in the Netherlands. European Journal of Cancer. 88. 31–37. 100 indexed citations
16.
Wibin, E., et al.. (1995). Are perforated gastroduodenal ulcers related to Helicobacter pylori infection?. PubMed. 58(2). 208–12. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Kara Judson Breakdown of academic impact, for papers by Henrique Mantoan Breakdown of academic impact, for papers by Herbert Diebolder Breakdown of academic impact, for papers by J. Lang Breakdown of academic impact, for papers by Levon Badiglian‐Filho Breakdown of academic impact, for papers by Bjoern Lampe Breakdown of academic impact, for papers by M. Amoroso Breakdown of academic impact, for papers by Lillian Yuri Kumagai Breakdown of academic impact, for papers by Carlos Chaves Faloppa Breakdown of academic impact, for papers by Marjolein Kleppe
Rankless by CCL
2026